Scientific article
English

Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant

Published inExpert opinion on pharmacotherapy, vol. 15, no. 7, p. 953-959
Publication date2014
Abstract

Diabetic macular edema (DME) can be treated with intravitreal glucocorticoids, particularly triamcinolone acetonide, dexamethasone (DEX), and fluocinolone acetonide (FA).

Keywords
  • Animals
  • Delayed-Action Preparations/chemistry
  • Dexamethasone/administration & dosage/therapeutic use
  • Diabetic Retinopathy/complications/drug therapy
  • Drug Implants/administration & dosage/therapeutic use
  • Fluocinolone Acetonide/administration & dosage/therapeutic use
  • Glucocorticoids/administration & dosage/therapeutic use
  • Humans
  • Intravitreal Injections
  • Macular Edema/complications/drug therapy
  • Triamcinolone Acetonide/administration & dosage/therapeutic use
Citation (ISO format)
CIULLA, Thomas A et al. Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant. In: Expert opinion on pharmacotherapy, 2014, vol. 15, n° 7, p. 953–959. doi: 10.1517/14656566.2014.896899
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1465-6566
442views
0downloads

Technical informations

Creation11/30/2016 9:27:00 AM
First validation11/30/2016 9:27:00 AM
Update time03/15/2023 1:11:21 AM
Status update03/15/2023 1:11:21 AM
Last indexation10/31/2024 5:38:21 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack